Literature DB >> 26730066

Cytological Study of Breast Carcinoma Before and After Oncotherapy with Special Reference to Morphometry and Proliferative Activity.

Sananda Koley1, Srabani Chakrabarti2, Swapan Pathak2, Asim Kumar Manna3, Siddhartha Basu4.   

Abstract

Our study was done to assess the cytological changes due to oncotherapy in breast carcinoma especially on morphometry and proliferative activity. Cytological aspirates were collected from a total of 32 cases of invasive ductal carcinoma both before and after oncotherapy. Morphometry was done on the stained cytological smears to assess the different morphological parameters of cell dimension by using the ocular morphometer and the software AutoCAD 2007. Staining was done with Ki-67 and proliferating cell nuclear antigen (PCNA) as proliferative markers. Different morphological parameters were compared before and after oncotherapy by unpaired Student's t test. Statistically significant differences were found in morphometric parameters, e.g., mean nuclear diameter, mean nuclear area, mean cell diameter, and mean cell area, and in the expression of proliferative markers (Ki-67 and PCNA). Statistical analysis was done by obtaining p values. There are statistically significant differences between morphological parameter of breast carcinoma cells before and after oncotherapy.

Entities:  

Keywords:  Breast carcinoma; Morphometry; Oncotherapy; Proliferative activity

Year:  2013        PMID: 26730066      PMCID: PMC4692923          DOI: 10.1007/s12262-013-0928-y

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  11 in total

1.  An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades.

Authors:  Balkrishna B Yeole; A P Kurkure
Journal:  Asian Pac J Cancer Prev       Date:  2003 Jan-Mar

2.  Assignment of the human Ki-67 gene (MK167) to 10q25-qter.

Authors:  C Fonatsch; M Duchrow; H Rieder; C Schlüter; J Gerdes
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

3.  Effect of radiotherapy on oral mucosa assessed by quantitative exfoliative cytology.

Authors:  G R Ogden; J G Cowpe; M W Green
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

4.  Current status of breast cancer in Hong Kong.

Authors:  L W Chow; A C Ting; K L Cheung; G K Au; T T Alagaratnam
Journal:  Chin Med J (Engl)       Date:  1997-06       Impact factor: 2.628

5.  Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer.

Authors:  T Tanei; A Shimomura; K Shimazu; T Nakayama; S J Kim; T Iwamoto; Y Tamaki; S Noguchi
Journal:  Eur J Surg Oncol       Date:  2010-12-15       Impact factor: 4.424

6.  Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway.

Authors:  Grethe Albrektsen; Ivar Heuch; Steinar Ø Thoresen
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

7.  Evaluation of risk factors, diagnosis and treatment in carcinoma breast--a retrospective study.

Authors:  S Bhattacharya; S Adhikary
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2006 Jan-Mar

8.  Chemotherapy-induced histologic changes in mastectomy specimens and their potential significance.

Authors:  N Sneige; B Kemp; L Pusztai; L Asmar; G N Hortobagyi
Journal:  Breast       Date:  2001-12       Impact factor: 4.380

9.  Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form.

Authors:  N H Waseem; D P Lane
Journal:  J Cell Sci       Date:  1990-05       Impact factor: 5.285

10.  The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma.

Authors:  S A Rasbridge; C E Gillett; A M Seymour; K Patel; M A Richards; R D Rubens; R R Millis
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

View more
  1 in total

1.  Label-free multiphoton imaging to assess neoadjuvant therapy responses in breast carcinoma.

Authors:  Lianhuang Li; Zhonghua Han; Lida Qiu; Deyong Kang; Zhenlin Zhan; Haohua Tu; Jianxin Chen
Journal:  Int J Biol Sci       Date:  2020-02-21       Impact factor: 6.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.